Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

118 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Inhibition of sodium-glucose cotransporter-2 and liver-related complications in individuals with diabetes: a Mendelian randomization and population-based cohort study.
Chung SW, Moon HS, Shin H, Han H, Park S, Cho H, Park J, Hur MH, Park MK, Won SH, Lee YB, Cho EJ, Yu SJ, Kim DK, Yoon JH, Lee JH, Kim YJ. Chung SW, et al. Among authors: hur mh. Hepatology. 2024 Mar 11. doi: 10.1097/HEP.0000000000000837. Online ahead of print. Hepatology. 2024. PMID: 38466796
Long-Term Outcomes of Transarterial Radioembolization for Large Single Hepatocellular Carcinoma: A Comparison to Resection.
Kim J, Kim JY, Lee JH, Sinn DH, Hur MH, Hong JH, Park MK, Cho HJ, Choi NR, Lee YB, Cho EJ, Yu SJ, Kim YJ, Paeng JC, Kim HC, Yi NJ, Lee KW, Suh KS, Hyun D, Kim JM, Yoon JH. Kim J, et al. Among authors: hur mh. J Nucl Med. 2022 Aug;63(8):1215-1222. doi: 10.2967/jnumed.121.263147. Epub 2021 Dec 9. J Nucl Med. 2022. PMID: 34887340 Free article.
Comparison of the outcomes between sorafenib and lenvatinib as the first-line systemic treatment for HBV-associated hepatocellular carcinoma: a propensity score matching analysis.
Choi NR, Kim JY, Hong JH, Hur MH, Cho H, Park MK, Kim J, Lee YB, Cho EJ, Lee JH, Yu SJ, Yoon JH, Kim YJ. Choi NR, et al. Among authors: hur mh. BMC Gastroenterol. 2022 Mar 25;22(1):135. doi: 10.1186/s12876-022-02210-3. BMC Gastroenterol. 2022. PMID: 35337274 Free PMC article. Clinical Trial.
Correlation between Results of Semi-Quantitative and Quantitative Tests for Hepatitis B Virus Surface Antigen among Patients Achieving Viral Suppression with Antiviral Treatment.
Chung GE, Kim JY, Shin H, Hong JH, Hur MH, Cho H, Park MK, Choi NR, Kim J, Lee YB, Cho EJ, Yu SJ, Kim YJ, Yoon JH, Lee JH. Chung GE, et al. Among authors: hur mh. Diagnostics (Basel). 2022 Jul 20;12(7):1757. doi: 10.3390/diagnostics12071757. Diagnostics (Basel). 2022. PMID: 35885659 Free PMC article.
Personalized Antiviral Drug Selection in Patients With Chronic Hepatitis B Using a Machine Learning Model: A Multinational Study.
Hur MH, Park MK, Yip TC, Chen CH, Lee HC, Choi WM, Kim SU, Lim YS, Park SY, Wong GL, Sinn DH, Jin YJ, Kim SE, Peng CY, Shin HP, Chen CY, Kim HY, Lee HA, Seo YS, Jun DW, Yoon EL, Sohn JH, Ahn SB, Shim JJ, Jeong SW, Cho YK, Kim HS, Jang MJ, Kim YJ, Yoon JH, Lee JH. Hur MH, et al. Am J Gastroenterol. 2023 Nov 1;118(11):1963-1972. doi: 10.14309/ajg.0000000000002234. Epub 2023 Mar 7. Am J Gastroenterol. 2023. PMID: 36881437
Transarterial chemoembolization as an alternative to radioembolization is associated with earlier tumor recurrence than in radioembolization-eligible patients.
Chung SW, Cho H, Shin H, Park J, Kim JY, Hong JH, Hur MH, Park MK, Lee YB, Yu SJ, Lee M, Kim YJ, Paeng JC, Yoon JH, Chung JW, Lee JH, Kim HC. Chung SW, et al. Among authors: hur mh. Front Oncol. 2023 Feb 28;13:1081479. doi: 10.3389/fonc.2023.1081479. eCollection 2023. Front Oncol. 2023. PMID: 36925930 Free PMC article.
118 results